Approval · Notice of Compliance 22496 · 2019
VOTRIENT: Notice of Compliance 22496
Issued August 1, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22496
- Date
- August 1, 2019
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Safety update to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VOTRIENT | Not yet assigned | — |
Medicinal ingredients
- PAZOPANIB HYDROCHLORIDE 200 MG per TAB
- PAZOPANIB HYDROCHLORIDE 400 MG per TAB